Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 9 10 11 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Immunic, Inc.. (10/10/22). "Press Release: Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing". New York, NY. 2022-10-10
IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried. 2022-10-07
ArchiMed SAS. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist". 2022-10-07
High-Tech Gründerfonds Management GmbH. (10/6/22). "Press Release: Real-Time Monitoring of Bioprocesses. Irubis Closes EUR 2.8m Seed Round Led by HTGF, Verve Ventures and Ventura BioMed Investors". Munich. 2022-10-06
T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg. 2022-10-06
Terraplasma GmbH. (10/6/22). "Press Release: Election of an Advisory Board for Terraplasma. Extensive Industry Expertise". Garching. 2022-10-06
HeartBeat.bio AG. (10/5/22). "Press Release: HeartBeat.bio Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna. 2022-10-05
BioRiver – Life Science im Rheinland e.V.. (10/5/22). "Press Release: Three Disruptive Approaches in Biotechnology and Medicine Win the BioRiver Boost! 2022 Biotech Start-up Competition". Düsseldorf & Hilden. 2022-10-05
Araris Biotech AG. (10/4/22). "Press Release: Araris Biotech Closes $24 Million Financing Round". Zurich. 2022-10-04
Aurobac Therapeutics SAS. (10/4/22). "Press Release: Aurobac Therapeutics, the Joint Venture Recently Created by Boehringer Ingelheim, Evotec and bioMérieux, Appoints Florence Séjourné as Chief Executive Officer". Lyon. 2022-10-04
Sibylla Biotech S.p.A.. (10/4/22). "Press Release: Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform". Verona. 2022-10-04
Valneva S.E.. (10/4/22). "Press Release: Valneva Announces Closing of Upsized €102.9 Million Global Offering". Saint-Herblain. 2022-10-04
BioM Biotech Cluster Development GmbH. (9/30/22). "Press Release: Prof. Ralf Huss Appointed as New Managing Director of BioM Biotech Cluster Development GmbH". 2022-09-30
Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. 2022-09-30
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
Assay.Works GmbH. (9/29/22). "Press Release: Partex Welcomes Assay.Works to Its Digital Pharma Platform". Eschborn & Regensburg. 2022-09-29
Pureos Partners AG. (9/28/22). "Press Release: Pureos Partners Welcomes Dr. Veronica Gambillara Fonck as New Partner to Its Investment Team". Pfäffikon. 2022-09-28
High-Tech Gründerfonds Management GmbH. (9/28/22). "Press Release: GS Bavaria Closes Seven-figure Seed Round for Scaling Tungsten Particles as Sustainable Additive in Composites". 2022-09-28
BRAIN Biotech AG. (9/27/22). "Press Release: Change in the Executive Management Board of BRAIN Biotech AG, Genome Editing Activities Established Under the Akribion Genomics brand". Zwingenberg. 2022-09-27
NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". 2022-09-27
Arsenal Biosciences, Inc.. (9/27/22). "Press Release: Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech to Identify Features of Successful T-Cell Therapies for Oncology". South San Francisco, CA. 2022-09-27
Navigo Proteins GmbH. (9/26/22). "Press Release: Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19". Halle (Saale). 2022-09-26
Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld. 2022-09-26
Catalym GmbH. (9/26/22). "Press Release: Catalym Receives FDA IND Clearance to Expand Development of Visugromab in Advanced Cancer Patients into the U.S.". Munich. 2022-09-26
c-LEcta GmbH. (9/23/22). "Press Release: OFB Starts Construction Work for »BioSquare Leipzig« Technology Campus". 2022-09-23
Biovian Oy. (9/22/22). "Press Release: Biovian Announces the Appointment of a New Board Member. Dr. Uwe Gottschalk Has Joined Biovian’s Board of Directors". 2022-09-22
Adapsyn Bioscience Inc.. (9/21/22). "Press Release: Adapsyn Bioscience Enters into Strategic Collaboration with Evotec". Hamilton, ON. 2022-09-21
Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai. 2022-09-21
Merck KGaA. (9/21/22). "Press Release: Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor [ Not intended for US- or Canada- and UK-based media ]". Darmstadt. 2022-09-21
Hedera Dx S.A.. (9/21/22). "Press Release: Hedera Dx Raises €14 Million in Seed Funding to Accelerate Global Adoption of Liquid Biopsies". Lausanne. 2022-09-21
ECBF Management GmbH. (9/20/22). "Press Release: ECBF Leads €10m Series B Investment in Digital Pest Monitoring Provider Trapview to Expand Its Sustainable Agriculture Technology Portfolio". Luxembourg. 2022-09-20
Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin. 2022-09-20
Evotec SE. (9/20/22). "Press Release: Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense under Accelerated Antibodies Program". Hamburg. 2022-09-20
Avelo AG. (9/20/22). "Press Release: Avelo Closes CHF 2.2 Million Oversubscribed Seed Round". 2022-09-20
Scailyte AG. (9/19/22). "Press Release: Scailyte Closes Series A Funding with a CHF 6 Million Investment". 2022-09-19
Genfit S.A.. (9/19/22). "Press Release: Genfit to Acquire Clinical-stage Biopharmaceutical Company Versantis, Expanding Its Portfolio in Liver Diseases". Lille & Cambridge, MA. 2022-09-19
Evotec SE. (9/16/22). "Press Release: Evotec Initiates Ground-breaking for New Biologics Facility J.POD Toulouse, France (EU)". Hamburg. 2022-09-16
Eppendorf SE. (9/16/22). "Press Release: Eppendorf Expands High-tech Site in Jülich and Celebrates Topping-out Ceremony for Multifunctional Building". Jülich & Hamburg. 2022-09-16
Tricares SAS. (9/15/22). "Press Release: Tricares Raises €47m in a First Closing of Its Series C Financing to Fund Further Development of Minimally Invasive Treatment for Tricuspid Regurgitation". Paris & Munich. 2022-09-15
Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin. 2022-09-15
Forever Healthy Foundation gGmbH. (9/15/22). "Press Release: Rejuvenation Startup Summit 2022 Announces Program and Speakers". 2022-09-15
Tridek-One SAS. (9/15/22). "Press Release: Tridek-One Closes a €16 Million Financing Round to Develop First-in-Class Immune Checkpoint Agonists". Paris. 2022-09-15
Kuros Biosciences AG. (9/15/22). "Press Release: Kuros Biosciences Announces Successful CHF 6.0 Million Private Placement (Ad-hoc announcement pursuant to Article 53 of the SIX listing rules)". Schlieren. 2022-09-15
T-Curx GmbH. (9/15/22). "Press Release: Caroline Burger, PhD, Appointed as T-Curx' Global Head Business Development". Würzburg. 2022-09-15
Capstan Therapeutics, Inc.. (9/14/22). "Press Release: Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering". San Diego, CA & Philadelphia, PA. 2022-09-14
Scienion AG. (9/13/22). "Press Release: Scienion and Cellenion Launch the proteoCHIP LF 48, for Label-free Single-cell Proteomics Sample Preparation on the cellenONE platform". Berlin & Lyon. 2022-09-13
HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA. 2022-09-12
Precirix N.V.. (9/12/22). "Press Release: Precirix Enters into Collaboration with Eckert & Ziegler for the Development of Its 68Ga-based Compounds". Brussels & Berlin. 2022-09-12
Immatics N.V.. (9/10/22). "Press Release: Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022". Houston, TX & Tübingen. 2022-09-10
Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg. 2022-09-09
genOway S.A.. (9/8/22). "Press Release: Sigma-Aldrich and genOway Expand Their CRISPR/Cas9 Strategic Alliance". St. Louis, MO & Lyon. 2022-09-08
faCelliate GmbH. (9/7/22). "Press Release: faCellitate, a BASF Spin-off, Closes a €3.7m Seed Round Led by Sarstedt and HTGF". Mannheim. 2022-09-07
Indivumed GmbH. (9/7/22). "Press Release: Indivumed and CellPhenomics Announce Partnership for Improved Cancer Patient Care". Berlin & Hamburg. 2022-09-07
QLi5 Therapeutics GmbH. (9/7/22). "Press Release: QLi5 Therapeutics Attracts EUR 10 Million in Series A Financing". Dortmund. 2022-09-07
Biosynth AG. (9/7/22). "Press Release: Biosynth Carbosynth, Vivitide and Pepscan Rebrand to Biosynth". Staad. 2022-09-07
PhoreMost Ltd.. (9/6/22). "Press Release: PhoreMost Enters Multi-project Drug Target Discovery Collaboration with Roche". Cambridge. 2022-09-06
ADC Therapeutics S.A.. (9/6/22). "Press Release: ADC Therapeutics to Participate in Morgan Stanley’s 20th Annual Global Healthcare Conference". Lausanne. 2022-09-06
EMBL. (9/6/22). "Press Release: ERC Proof-of-Concept Grant Provides Way to Realise Commercial Potential of ‘SpaceM’ Technology". 2022-09-06
Emergence Therapeutics AG. (9/6/22). "Press Release: Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal". Amsterdam & Duisburg. 2022-09-06
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Launches, Founded by Cumulus Oncology and in Partnership with the Lead Discovery Center, to Focus on Developing First and Best-in-Class Molecules Inhibiting Novel DNA Damage Response Targets". 2022-09-06
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Announces Acquisition of Basilea Pharmaceutica’s PARG Inhibitor Programme". Edinburgh. 2022-09-06
Arcensus GmbH. (9/5/22). "Press Release: Dammam Valley/KSA to Acquire the Majority of Arcensus GmbH/Germany to Accelerate the Global implementation of Whole Genome Sequencing in Genetic Diagnostics and Delivery of Breakthrough Technologies in Genomic Bio 2022-09-05
Boehringer Ingelheim. (9/2/22). "Press Release: U.S. FDA Approves First Treatment Option for Generalized Pustular Psoriasis Flares in Adults". Ingelheim. 2022-09-02
BioEcho Life Sciences GmbH. (9/2/22). "Press Release: BioEcho Life Sciences Announces Expansion with New US Subsidiary". Cologne. 2022-09-02
Ginkgo Bioworks Inc.. (9/1/22). "Press Release: Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing and Life Science Tools". Boston, MA. 2022-09-01
C-mo Medical Solutions. (9/1/22). "Press Release: C-mo Medical Solutions Raises €4.1 Million Aiming to Transform Cough Monitoring". Lisbon. 2022-09-01
AiCuris Anti-infective Cures AG. (9/1/22). "Press Release: AiCuris Appoints Experienced Business Leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer". Wuppertal. 2022-09-01
Agilent Technologies Inc.. (9/1/22). "Press Release: Agilent Collaborates with Mettler Toledo to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results". Santa Clara, CA. 2022-09-01
Carbios S.A.. (9/1/22). "Press Release: Carbios Strengthens Executive Committee with the Appointment of Pascal Bricout as Chief Strategy & Financial Officer". Clermont-Ferrand. 2022-09-01
Dynamic Biosensors GmbH. (9/1/22). "Press Release: 2bind and Dynamic Biosensors Sign Technology-Service Partnership". Munich & Regensburg. 2022-09-01
Novartis AG. (9/1/22). "Press Release: Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., Steps Down from the Executive Committee of Novartis". Basel. 2022-09-01
Affimed N.V.. (9/1/22). "Press Release: Affimed to Present at Upcoming Investor Conferences". Heidelberg. 2022-09-01
BioNTech SE. (9/1/22). "Press Release: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union". New York, NY & Mainz. 2022-09-01
Centogene N.V.. (9/1/22). "Press Release: Centogene to Present at Upcoming Investor & Partnering Conferences in September". Cambridge, MA, Rostock & Berlin. 2022-09-01
InfanDx AG. (9/1/22). "Press Release: InfanDx AG Appoints Nicole Witzmann as Chief Financial Officer". Cologne, Berlin & Boston, MA. 2022-09-01
Life Science Valley GmbH. (9/22). "Pressemitteilung: Life Science Valley erhält Projektförderung vom Land Niedersachsen". 2022-09-01
MorphoSys AG. (8/31/22). "Press Release: MorphoSys Appoints Tim Demuth as New Chief Research and Development Officer, Following the Retirement of Malte Peters". Planegg. 2022-08-31
BioNTech SE. (8/31/22). "Press Release: Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older". New York, NY & Mainz. 2022-08-31
CRISPR Therapeutics AG. (8/31/22). "Press Release: CRISPR Therapeutics to Participate in Upcoming Investor Conferences". Zug & Cambridge, MA. 2022-08-31
Heidelberg Pharma AG. (8/30/22). "Press Release: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure [ Not for US, CA, et al.]". Ladenburg. 2022-08-30
Formycon AG. (8/29/22). "Press Release: European Commission Approves FYB201/Ranivisio (Ranivisio - Ranibizumab), a Biosimilar to Lucentis". Munich, Amsterdam & Zug. 2022-08-29
Moderna, Inc.. (8/26/22). "Press Release: Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform". Cambridge, MA. 2022-08-26
Evotec SE. (8/25/22). "Press Release: Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany". Hamburg. 2022-08-25
Novartis AG. (8/25/22). "Press Release: Novartis Announces Intention to Separate Sandoz Business to Create a Standalone Company by Way of a 100% Spin-off". Basel. 2022-08-25
Oncgnostics GmbH. (8/25/22). "Press Release: German Oncgnostics GmbH‘s Innovation in the Area of Cervical Cancer Diagnostics Now also Available in China". Jena. 2022-08-25
Roche. (8/23/22). "Press Release: Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight against Cancer and other Diseases". Basel. 2022-08-23
Evolva Holding S.A.. (8/23/22). "Press Release: Evolva Statement to SER Communication. Evolva Takes Note of the Sanction Request Submitted by SIX Exchange Regulation (SER) Today". Reinach. 2022-08-23
Immatics N.V.. (8/23/22). "Press Release: Immatics Announces First Cancer Patient Treated with Second-generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME". Houston, TX & Tübingen. 2022-08-23
BioNTech SE. (8/22/22). "Press Release: Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine". New York, NY & Mainz. 2022-08-22
Vaderis Therapeutics AG. (8/22/22). "Press Release: Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT". Basel. 2022-08-22
BioInnovation Institute (BII). (8/22/22). "Press Release: BII Supports Three International Start-ups Developing Pioneering Science in the Therapeutics and Health Tech Space". 2022-08-22
Kinarus Therapeutics Holding AG. (8/22/22). "Press Release: Kinarus Announces the Issuance of Convertible Notes of up to CHF 20 Million to an Entity Managed by Yorkville [ not for any jurisdiction where unlawful]". Basel. 2022-08-22
HMNC Holding GmbH. (8/22/22). "Press Release: Maximilian Doebler Appointed Chief Business Officer of HMNC Brain Health". Munich. 2022-08-22
Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain. 2022-08-18
Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA. 2022-08-18
SHS Gesellschaft für Beteiligungsmanagement mbH. (8/18/22). "Press Release: SHS Appoints Manfred Ulmer-Weber to the Management Board". Tübingen. 2022-08-18
ADC Therapeutics S.A.. (8/15/22). "Press Release: ADC Therapeutics Announces $175 Million Senior Secured Term Loan from Owl Rock and Oaktree and Settlement of Existing Senior Secured Convertible Notes". Lausanne. 2022-08-15
Medicines Discovery Catapult (MDC). (8/11/22). "Press Release: Medicines Discovery Catapult and Zeiss Set Sights on Advancing Microscopy. Driving the Application of Microscopy in Drug Discovery". 2022-08-11
ChemDiv, Inc.. (8/11/22). "Press Release: ChemDiv and Jacobs University Announce Strategic Partnership in Drug Discovery". San Diego, CA & Bremen. 2022-08-11
Rentschler Biopharma SE. (8/10/22). "Press Release: Rentschler Biopharma Expands Leadership Team with Senior-level Hires". Laupheim. 2022-08-10
next pagenext page 1 2 3 ... 9 10 11 ... 35 36 37  next pagenext page



Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top